# 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

> **NCT01993160** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 50 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Fluorocholine (18F-FCH) Injection
- **RADIATION:** PET scan
- **RADIATION:** Whole body MRI

## Key facts

- **NCT ID:** NCT01993160
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01993160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01993160, "18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01993160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*